MUCINEX CHILDREN’S launches MIGHTY CHEWS
MUCINEX CHILDREN’S LAUNCHES MIGHTY CHEWS, THE FIRST OVER-THE-COUNTER MEDICATED CHILDREN’S SOFT CHEW FOR COUGH RELIEF The...
BioAI and Arbele Bio partner for AI-powered oncology clinical trials
BioAI Announces Strategic Partnership with Arbele Bio to advance Predictive AI-Models in Oncology Clinical Trials MANCHESTER, N.H., Sept....
MeMed BV test reduces antibiotic overuse in first US interventional trial
MeMed BV Test Demonstrates Antibiotic Overuse Reduction in First US Interventional Trial —First Multi-Center Randomized Controlled...
2024 Deloitte-NASCIO Survey: States Face Cyber Threats, Budget Limits
2024 Deloitte-NASCIO Survey Finds States Face Growing Cybersecurity Threats, Tight Budgets Nearly three-quarters of state chief information...
Emmes Group recognized as a top EDC platform by Everest Group
Emmes Group recognized as a top EDC platform by Everest Group Emmes Group named a ‘Major Contender’ in the Life Sciences Electronic...
Survey: 80% Fear ID Theft, But Only 16% Have Protection
SURVEY: Consumers Are Ignoring Cybersecurity Risks Despite Identify Theft Concerns AI-driven identify theft and deepfakes are top...
CSL & Arcturus: sa-mRNA COVID Vaccine Superior to Comirnaty
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination...
Neeve Secures $15M to Transform Cloud for Smart Buildings
Neeve secures $15 million to revolutionize cloud infrastructure for smart buildings SAN FRANCISCO, Sept. 30, 2024 /PRNewswire/ — Neeve...
Biohaven Begins Pivotal Trial for New Migraine Treatment Drug
Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine NEW HAVEN, Conn., Sept. 30, 2024 /PRNewswire/...
Women in HVACR Hosts 21st Annual Dallas Convention
Women in HVACR Hosts 21st Annual Convention in Dallas. The nonprofit organization’s conference will feature a marketing guru and a rocket...
